The pharma giant has raised its dividends annually for 54 consecutive years. AbbVie has a large pipeline of mid- and ...
New research advances an Epstein–Barr virus vaccine, while another study detects higher levels of microplastics in prostate cancer tumors.
Marie Hindee experienced a breakthrough in her 15-year battle with chronic lymphocytic leukemia and small lymphocytic lymphoma after undergoing a cutting-edge therapy at Corewell Health Beaumont ...
First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY ...
The potential of STAR-LLD to improve lenalidomide’s therapeutic index suggests an opportunity for use in combination with CAR-T cell therapies.As ...
February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some of the most challenging diagnoses in modern medicine. From the introduction ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and ...
“Many confounding factors in real life—including lifestyle, UV exposure, occupational hazards, and immune status—can ...
The potential of STAR-LLD to improve lenalidomide’s therapeutic index suggests an opportunity for use in combination with multi-specific (i.e.
XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South ...
President Trump this week issued an executive order that seeks to boost the controversial herbicide glyphosate, drawing ire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results